The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
JNK signaling in cancer cell survival
Abstract
c‐Jun N‐terminal kinase (JNK) is involved in cancer cell apoptosis; however, emerging evidence indicates that this Janus signaling promotes cancer cell survival. JNK acts synergistically with NF‐κB, JAK/STAT, and other signaling molecules to exert a survival function. JNK positively regulates autophagy to counteract apoptosis, and its effect on autophagy is related to the development of chemotherapeutic resistance. The prosurvival effect of JNK may involve an immune evasion mechanism mediated by transforming growth factor‐β, toll‐like receptors, interferon‐γ, and autophagy, as well as compensatory JNK‐dependent cell proliferation. The present review focuses on recent advances in understanding the prosurvival function of JNK and its role in tumor development and chemoresistance, including a comprehensive analysis of the molecular mechanisms underlying JNK‐mediated cancer cell survival. There is a focus on the specific “Yin and Yang” functions of JNK1 and JNK2 in the regulation of cancer cell survival. We highlight recent advances in our knowledge of the roles of JNK in cancer cell survival, which may provide insight into the distinct functions of JNK in cancer and its potential for cancer therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The JAK/STAT pathway interacts with the RAS/MAPK and NF-κB signaling pathways, forming a complex network of cross-talk that influences various cellular processes, including cell proliferation, survival, and apoptosis.”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [118]
In the citing paper
“However, the JAK/STAT pathway, through its downstream effector Zfh2, can control the expression of the fos gene and the pro-apoptotic hid gene, thereby promoting cell survival mediated by JNK and inhibiting JNK-induced cell apoptosis [118].”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [118]
Citations
Cites
3 retracted
Sui, X., Kong, N., Wang, X., Fang, Y., Hu, X., Xu, Y., Chen, W., Wang, K., Li, D., Jin, W., et al. (2014) · Scientific Reports · doi:10.1038/srep04694 · Cited by 96
Self-citationRetractedVarı́, R., Scazzocchio, B., Santangelo, C., Filesi, C., Galvano, F., D’Archivio, M., Masella, R., & Giovannini, C. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/351827 · Cited by 41
RetractedMihailidou, C., Papakotoulas, P., Papavassiliou, A. G., & Karamouzis, M. V. (2017) · Oncotarget · doi:10.18632/oncotarget.23164 · Cited by 31
RetractedPatterns of somatic mutation in human cancer genomes
Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2694 · Cited by 2,635
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Autophagy Is Activated for Cell Survival after Endoplasmic ReticulumStress
Ogata, M., Hino, S.-I., Saito, A., Morikawa, K., Kondo, S., Kanemoto, S., Murakami, T., Taniguchi, M., Tanii, I., Yoshinaga, K., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01453-06 · Cited by 1,832
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355
JNK1-Mediated Phosphorylation of Bcl-2 Regulates Starvation-Induced Autophagy
Wei, Y., Pattingre, S., Sinha, S., Bassik, M., & Levine, B. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.001 · Cited by 1,329
Cited by
Sorted by citations
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Wu, Q., Li, Y., Nepovimová, E., Heger, Z., Wu, W., Kuča, K., & Adam, V. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01292-6 · Cited by 518
Self-citationHypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis
Fuhrmann, D. C., Mondorf, A. W., Beifuß, J., Jung, M., & Brüne, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101670 · Cited by 415
The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
Hammouda, M., Ford, A. E., Liu, Y., & Zhang, J. Y. (2020) · Cells · doi:10.3390/cells9040857 · Cited by 296
Selective inhibitors for JNK signalling: a potential targeted therapy in cancer
Wu, Q., Wu, W., Jacevic, V. M., França, T. C. C., Wang, X., & Kuča, K. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1720013 · Cited by 172
Self-citationMacrophage-based nanotherapeutic strategies in ulcerative colitis
Zhang, J., Zhao, Y., Hou, T., Zeng, H., Kalambhe, D., Wang, B., Shen, X., & Huang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.047 · Cited by 160
Ma, N., Zhang, J., Reiter, R. J., & Ma, X. (2019) · Medicinal Research Reviews · doi:10.1002/med.21628 · Cited by 155
Antitumor Effects of Carvacrol and Thymol: A Systematic Review
Sampaio, L. A., Pina, L. T. S., Serafini, M. R., Tavares, D. D. S., & Guimarães, A. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.702487 · Cited by 158
Current scenario of indole derivatives with potential anti-drug-resistant cancer activity
Jia, Y., Wen, X., Gong, Y., & Wang, X. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112359 · Cited by 149
Self-citationReceptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
Dev, S. S., Abidin, S. A. Z., Farghadani, R., Othman, I., & Naidu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.772510 · Cited by 154
Two-Faced: Roles of JNK Signalling During Tumourigenesis in the Drosophila Model
La Marca, J. E., & Richardson, H. E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00042 · Cited by 139
Wu, Q., Qin, Z., Kuča, K., You, L., Zhao, Y., Liu, A., Musílek, K., Chrienová, Ž., Nepovimová, E., Olekšák, P., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02899-9 · Cited by 109
Self-citationThe role of JNK in prostate cancer progression and therapeutic strategies
Xu, R., & Hu, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109679 · Cited by 102
Zhang, G., Gao, Z.-X., Guo, X., Ma, R., Wang, X., Zhou, P., Li, C., Tang, Z., Zhao, R., & Gao, P. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166224 · Cited by 94
Self-citationLipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
Iturbe-Rey, S., Maccali, C., Arrese, M. A., Aspichueta, P., de Oliveira, C. P. M. S., Castro, R. E., Lapitz, A., Izquierdo‐Sánchez, L., Bujanda, L., Perugorria, M. J., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119053 · Cited by 102
Jia, Y., Tian, C., Wang, H., Fan, Y., Lv, W., Duan, Y., Cheng, Z., Wang, X., Wang, Y., Liu, T., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01455-y · Cited by 90
Self-citationMultiple myeloma: signaling pathways and targeted therapy
Lu, Q., Yang, D., Li, H., Niu, T., & Tong, A. (2024) · Molecular biomedicine · doi:10.1186/s43556-024-00188-w · Cited by 90
JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases
Musi, C. A., Agrò, G., Santarella, F., Iervasi, E., & Borsello, T. (2020) · Cells · doi:10.3390/cells9102190 · Cited by 78
RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway
Zhang, D., Jiang, Q., Ge, X., Shi, Y., Ye, T., Mi, Y., Xie, T., Li, Q., & Ye, Q. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59939 · Cited by 79
Zhou, R., Ying, J., Qiu, X., Yu, L., Yue, Y., Liu, Q., Shi, J., Li, X., Qu, Y., & Mu, D. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002010 · Cited by 78
Wang, Y., Zhao, W., Xiao, Z., Guan, G., Liu, X., & Zhuang, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14938 · Cited by 74
Role of K63-linked ubiquitination in cancer
Cao, L., Liu, X., Zheng, B., Xing, C., & Liu, J. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01204-0 · Cited by 75
Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
Ji, Z., Shen, J., Lan, Y., Yi, Q., & Liu, H. (2023) · MedComm · doi:10.1002/mco2.308 · Cited by 71
Purohit, M., Gupta, G., Afzal, O., Altamimi, A. S. A., Alzarea, S. I., Kazmi, I. A., Almalki, W. H., Gulati, M., Kaur, I. P., Singh, S. K., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110334 · Cited by 67
Lainetti, P. D. F., Leis‐Filho, A. F., Amorim, R. L., Battazza, A., & Fonseca‐Alves, C. E. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121193 · Cited by 66
Emodin Induced Necroptosis and Inhibited Glycolysis in the Renal Cancer Cells by Enhancing ROS
Wang, K., Meng, X.-Y., Chen, J., Wang, K., Zhou, C., Yu, R., & Ma, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8840590 · Cited by 66
Wang, Y., Wang, Z., Li, S., Ma, J., Dai, X., & Lü, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111846 · Cited by 59
MAPK signaling pathway-targeted marine compounds in cancer therapy
Wei, J., Liu, R., Hu, X., Liang, T., Zhou, Z., & Huang, Z. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03460-y · Cited by 57
JNK in Tumor Microenvironment: Present Findings and Challenges in Clinical Translation
Tam, S. Y., & Law, H. (2021) · Cancers · doi:10.3390/cancers13092196 · Cited by 58
Tumour cells are sensitised to ferroptosis via RB1CC1‐mediated transcriptional reprogramming
Xue, X., Ma, L., Zhang, X., Xu, X., Guo, S., Wang, Y., Qiu, S., Cui, J., Guo, W., Yu, Y., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.747 · Cited by 59
An Update on the Effects of Probiotics on Gastrointestinal Cancers
Davoodvandi, A., Fallahi, F., Tamtaji, O. R., Tajiknia, V., Banikazemi, Z., Fathizadeh, H., Abbasi‐Kolli, M., Aschner, M., Ghandali, M., Sahebkar, A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.680400 · Cited by 59
The role of autophagy in idiopathic pulmonary fibrosis: from mechanisms to therapies
Yue, Y.-L., Zhang, M., Liu, J., Fang, L., & Qu, Y.-Q. (2022) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666221140972 · Cited by 60
Kim, N. Y., Mohan, C. D., Sethi, G., & Ahn, K. S. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30537 · Cited by 56
MAPK: A Key Player in the Development and Progression of Stroke
Zheng, Y., Han, Z., Zhao, H., & Luo, Y. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200613223018 · Cited by 50
JNK signaling as a target for anticancer therapy
Abdelrahman, K. S., Hassan, H. A., Abdel‐Aziz, S. A., Marzouk, A. A. E., Narumi, A., Konno, H., & Abdel‐Aziz, M. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00238-y · Cited by 52
The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway
Zhang, H., Wang, Y., Liu, C., Li, W., Zhou, F., Wang, X., & Zheng, J. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153746 · Cited by 50
Self-citationAprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation and Suppresses Inflammatory Pain
Yang, Y., Zhou, W., Xu, X., Sang, J., 葛贤秀, Wang, F., Zhang, G., Miao, L., & Deng, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.811584 · Cited by 50
Kubatka, P., Bojková, B., Nosálová, N., Huniadi, M., Samuel, S. M., Sreenesh, B., Hrkľová, G., Kajo, K., Horňák, S., Cizkova, D., et al. (2025) · The EPMA Journal · doi:10.1007/s13167-025-00407-6 · Cited by 56
Wu, Q., Wu, W., & Kuča, K. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110968 · Cited by 45
Self-citationModulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance
Chun, K., & Joo, S. H. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.017 · Cited by 52
Wu, J., Wang, D., Zhou, J., Li, J., Xie, R., Li, Y., Huang, J., Liu, B., & Qiu, J. (2022) · Phytotherapy Research · doi:10.1002/ptr.7614 · Cited by 44
CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy
Dong, Y., Qiu, J. F., Sun, M., Qi, D., Qu, H., Wang, X., & Quan, C. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02644-x · Cited by 43
Self-citationQiu, Y., Xu, J., Liao, W., Wen, Y., Jiang, S., Wen, J., & Zhao, C. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.04.008 · Cited by 43
Colorectal cancer inhibitory properties of polysaccharides and their molecular mechanisms: A review
Ruan, J., Zhang, P., Zhang, Q., Zhao, S., Dang, Z., Lu, M., Li, H., Zhang, Y., & Wang, T. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124165 · Cited by 42
Cho, Y.-L., Tan, H. W. S., Saquib, Q., Ren, Y., Ahmad, J., Wahab, R., He, W., Bay, B.-H., & Shen, H. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.03.027 · Cited by 40
Natural and Synthetic Lactones Possessing Antitumor Activities
Kim, Y., Sengupta, S., & Sim, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031052 · Cited by 40
ROS-mediated JNK pathway critically contributes to PFOS-triggered apoptosis in SH-SY5Y cells
Sun, P., Gu, L., Luo, J., Qin, Y., Sun, L., & Jiang, S. (2019) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2019.106821 · Cited by 39
The Promising Effects of Astaxanthin on Lung Diseases
Cheng, J., & Eroglu, A. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa143 · Cited by 41
MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
Matuszyk, J. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00516-2 · Cited by 41
He, T., Lin, X., Yang, C., Chen, Z., Wang, L., Li, Q., Ma, J., Zhan, F., Wang, Y., Jin, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8966368 · Cited by 38
Zhu, Y., Wen, S., Zhao, M., Pan, X., Pei, J., Wu, Y., Bu, F., Wang, A., Ouyang, L., & Wang, G. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01947 · Cited by 38
Photodynamic Therapy in Cancer: Insights into Cellular and Molecular Pathways
Papa, V., Furci, F., Minciullo, P. L., Casciaro, M., Allegra, A., & Gangemi, S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020069 · Cited by 36
Phytochemicals and cancer chemoprevention
Dave, A., Parande, F., Park, E., & Pezzuto, J. M. (2020) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.106 · Cited by 36
Liu, S., Tao, Y., Wu, S., Lin, J., Fu, S., Lu, J., Zhang, J., Fu, B., Zhang, E., Xu, J., et al. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00881-6 · Cited by 34
Self-citationEpithelial–mesenchymal transition to mitigate age-related progression in lung cancer
Thapa, R., Gupta, S., Gupta, G., Bhat, A. A., Smriti, Smriti, Ali, H., Singh, S. K., Dua, K., & Kashyap, M. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102576 · Cited by 34
MAPK signaling pathway in spinal cord injury: Mechanisms and therapeutic potential
Lin, F.-X., Gu, H.-Y., & He, W. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115043 · Cited by 35
Li, Y., Chen, F., Shen, W., Li, B., Xiang, R., Qu, L., Zhang, C., Gao, L., Xie, H., Katanaev, V. L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.011 · Cited by 34
Hypothemycin-Type Resorcylic Acid Lactones with Immunosuppressive Activities from a Podospora sp.
Gao, Y., Duan, F., Liu, L., Peng, X., Meng, X., & Ruan, H. (2021) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c01344 · Cited by 34
Paclitaxel Induces the Apoptosis of Prostate Cancer Cells via ROS-Mediated HIF-1α Expression
Zhang, Y., Tang, Y., Tang, X., Wang, Y., Zhang, Z., & Yang, H. (2022) · Molecules · doi:10.3390/molecules27217183 · Cited by 33
Cui, H., Zhao, Y.-Y., Wu, Q., You, Y., Lan, Z., Zou, K.-L., Cheng, G.-W., Chen, H., Han, Y.-H., Chen, Y., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.11.010 · Cited by 42
Self-citationYe, S., Hu, X., Sun, S., Su, B., Cai, J., & Jiang, J. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176620 · Cited by 33
Dou, Y., Jiang, X., Xie, H., He, J., & Xiao, S. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0573-6 · Cited by 33
Dong, K., Chen, Y., Yang, G., Liao, Z., Zhang, H., Liang, H., Chen, X., & Dong, H. (2019) · Oncogene · doi:10.1038/s41388-019-1107-9 · Cited by 33
Zheng, Q., Wang, Y.-C., Liu, Q., Dong, X., Xie, Z., Liu, X.-H., Gao, W., Bai, X., & Li, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117551 · Cited by 33
Xu, J., Yan, B., Zhang, L., Zhou, L., Zhang, J. C., Yu, W., Dong, X., Li, Y., & Shan, L. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s254693 · Cited by 33
Chen, B., Xu, X., Lin, D., Chen, X., Xu, Y., Liu, X., & Dong, W. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.635429 · Cited by 33
Hu, Q., Huang, Q.-X., Hong, H., Pan, Y., Luo, T. F., Li, J., Deng, Z., & Chen, F. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155131 · Cited by 32
JNK signaling and its impact on neural cell maturation and differentiation
Castro-Torres, R. D., Olloquequi, J., Parcerisas, A., Ureña, J. M., Ettcheto, M., Beas‐Zárate, C., Camins, A., Verdaguer, E., & Auladell, C. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122750 · Cited by 32
Xiang, Y., Wan, F., Ren, Y., Yang, D., Xiang, K., Zhu, B., Ruan, X., Li, S., Zhang, L., Liu, X., et al. (2023) · Phytotherapy Research · doi:10.1002/ptr.7986 · Cited by 33
Schepetkin, I. A., Karpenko, A., Khlebnikov, А. I., Shibinska, M. O., Levandovskiy, I. A., Kirpotina, L. N., Danilenko, N. V., & Quinn, M. T. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111719 · Cited by 34
Noncoding RNAs as sensors of tumor microenvironmental stress
Lv, Y., Lv, Y., Wang, Z., Yuan, K., & Zeng, Y. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02433-y · Cited by 31
Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer
Katayama, Y., Yamada, T., Tanimura, K., Tokuda, S., Morimoto, K., Hirai, S., Matsui, Y., Nakamura, R., Ishida, M., Kawachi, H., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00350-7 · Cited by 32
Cao, Y., Hu, L., Chen, R., Chen, Y., Liu, H., & Wei, J. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111702 · Cited by 32
Su, L., Wu, A., Zhang, W., & Kong, X. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1633338 · Cited by 29
RetractedMechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes
Shi, T., Kobara, H., Oura, K., & Masaki, T. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s274933 · Cited by 29
Shan, R.-R., Yu, J.-T., Zhang, S.-F., Xie, M.-M., Hou, R., Xie, C.-Y., Dong, Z.-H., Yang, Q., Hu, X.-W., Dong, Y.-H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155252 · Cited by 27
Cheikh, I. A., El‐Baba, C., Youssef, A., Saliba, N. A., Ghantous, A., & Darwiche, N. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2147920 · Cited by 30
Dou, X., Huang, H., Jiang, L., Zhu, G., Jin, H., Jiao, N., Zhang, L., Liu, Z., & Zhang, L. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112445 · Cited by 28
Zhao, R., Hu, Z., Zhang, X., Huang, S., Yu, G., Wu, Z. B., Yu, W., Lu, J., & Ruan, B. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01421-9 · Cited by 31
Huang, Z. L., Li, Y., Yan, Q., Zhai, E., Zhao, Z., Zhang, T., Liu, Y., Ye, L., Wei, R., Zhao, R., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07153-z · Cited by 27
Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
Aranza-Martínez, A., Sánchez-Pérez, J., Brito-Elías, L., López‐Camarillo, C., de León, D. F. C., Pérez‐Plasencia, C., & López–Urrutia, E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.752270 · Cited by 27
Sestrin2 in cancer: a foe or a friend?
Ala, M. (2022) · Biomarker Research · doi:10.1186/s40364-022-00380-6 · Cited by 27
Kaławaj, K., Sławińska-Brych, A., Mizerska-Kowalska, M., Żurek, A., Bojarska-Junak, A. A., Kandefer‐Szerszeń, M., & Zdzisińska, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249406 · Cited by 27
Cui, C., Zhang, H., Yang, C., Yin, M., Teng, X., Yang, M., Kong, D., Zhang, J., Peng, W., Chu, Z., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0940 · Cited by 26
The role of JNK signaling pathway in organ fibrosis
Hao, M., Lu, Y., Yao, Z., Wang, P., Chen, Z., Zhou, L., Yang, Q., Sang, X., Wang, K., & Cao, G. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.09.029 · Cited by 27
Anti-cancer potential of persimmon (Diospyros kaki) leaves via the PDGFR-Rac-JNK pathway
Kim, H.-S., Suh, J., Jang, Y., Ahn, S.-H., Ganesan, R., Kim, J., Jung, Y., Jung, S. H., & Kim, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-75140-3 · Cited by 26
Wang, S., Li, Z., Liu, W., Wei, G., Yu, N., & Ji, G. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500609 · Cited by 25
Kim, B., Kim, D.-M., Park, H., Kim, S., Hwang, M., Lee, J., Kang, M., Byun, J., Im, J., Kang, M., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02420-3 · Cited by 25
Huang, Z., Xiao, Z., Yu, L., Liu, J., Yang, Y., & Ouyang, W. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104284 · Cited by 29
Eosinophils promote CD8+ T cell memory generation to potentiate anti-bacterial immunity
Zhou, J., Liu, J., Wang, B., Li, N., Liu, J., Han, Y., & Cao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01752-0 · Cited by 25
Pharmacological properties and derivatives of saikosaponins—a review of recent studies
Zhu, Y., & Lai, Y. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad052 · Cited by 24
Liang, J., Bi, G., Huang, X., Xu, Z., Huang, Y., Bian, Y., Shan, G., Guo, W., Yan, Y., Sui, Q., et al. (2025) · 癌症:英文版 · doi:10.1002/cac2.70068 · Cited by 29
Antioxidant Effects of Irisin in Liver Diseases: Mechanistic Insights
Zhao, J., Qiao, L.-L., Dong, J., & Wu, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3563518 · Cited by 25
Deng, M., Wang, N., Li, Z., Chen, R., Duan, J., Peng, Y., Wu, Z., Zhang, Z., Jiang, L., Zheng, X. F. S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04614-1 · Cited by 25
Xu, D. C., Wang, L., Yamada, K. M., & Baena-López, L. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2022.110718 · Cited by 23
Gutierrez, N. M. C., Pujol‐Solé, N., Arifi, Q., Coll, J., Clainche, T. L., & Broekgaarden, M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10064-0 · Cited by 25
Zhang, J., Jian, P., Jiang, N., & Xu, L. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14463 · Cited by 24
Zhang, J., Xu, H., He, Y., Zheng, X. S., Lin, T., Yang, L., Tan, P., & Wei, Q. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103407 · Cited by 23
Natural products modulating MAPK for CRC treatment: a promising strategy
Zhou, L., Zhang, J., Zhao, K., Chen, B., & Sun, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1514486 · Cited by 23
LINC00958: A promising long non-coding RNA related to cancer
Li, H., Gao, J., Liu, L., & Zhang, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113087 · Cited by 23
Metadata
- Authors
- Wu, Q., Wu, W., Fu, B., Shi, L., Wang, X., & Kuca, K.
- Affiliations
- Nanjing Agricultural University (CN)
- Harvard University (US)
- University of Manchester (GB)
- Huazhong Agricultural University (CN)
- Department of Chemistry Faculty of Science, University of Hradec Kralove Hradec Kralove Czech Republic
- Corresponding author
- Wang, Xu
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2019-03-25
- Volume
- 39
- Issue
- 6
- Pages
- 2082-2104
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2923315793
- Cited by
- 322
- References
- 146
- Citations by year
- 2026: 22 · 2025: 51 · 2024: 68 · 2023: 42 · 2022: 56 · 2021: 43 · 2020: 29 · 2019: 11
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medicinal Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31572575, 31602114)
- China Postdoctoral Science Foundation (2016T90477)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- JNK signaling, c-Jun N-terminal kinase, tumor cell survival, apoptosis, NF-κB, JAK/STAT signaling, autophagy, chemoresistance, immune evasion, TGF-beta, Toll-like receptors, interferon-gamma, JNK1, JNK2, carcinogenesis, cell proliferation
- MeSH terms
- Animals, Autophagy, Cell Survival, Humans, Neoplasms, Drug Resistance, Neoplasm, MAP Kinase Signaling System, JNK Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review